Pronóstico del mercado de equipos y reactivos de transfección de Oriente Medio y África hasta 2030 – Análisis regional – por producto (reactivos e instrumentos), método (métodos virales, métodos no virales y métodos híbridos), aplicación (investigación biomédica, producción de proteínas y administración terapéutica) y usuario final (académicos e institutos de investigación y empresas farmacéuticas y de biotecnología)
La creciente popularidad de la terapia celular y génica refuerza el mercado de reactivos y equipos de transfección en Oriente Medio y África
Fabricación de terapia celular y génica Es un proceso complicado, lo que hace que su ejecución y seguimiento sean críticos. Los avances en biotecnología han llevado a la adopción de tratamientos personalizados para el tratamiento de numerosas indicaciones. Las terapias celulares y genéticas se utilizan principalmente para tratar enfermedades crónicas como trastornos neurológicos, cáncer y trastornos genéticos. Las ventajas notables de la terapia celular y genética incluyen un tratamiento dirigido, una recuperación más rápida y eficiente y una reducción de los efectos secundarios. Las terapias celulares y genéticas se adoptan ampliamente en todo el mundo debido a la disponibilidad de productos aprobados por la Administración de Alimentos y Medicamentos (FDA). Por ejemplo, la FDA aprobó un adenovirus ADSTILADRIN fabricado por Ferring Pharmaceuticals A/S en 2022. Este adenovirus recombinante (rAd-IFNa/Syn3) administra ADNc de interferón alfa-2b humano en el epitelio de la vejiga para tratar a pacientes que padecen ciertos tipos de cáncer de vejiga. . En 2022, CARVYKTI, fabricado por Janssen Biotech, Inc., también fue aprobado por la FDA. CARVYKTI es una célula CAR-T autóloga diseñada con lentivirus para atacar las células tumorales que expresan BCMA para el tratamiento de ciertos tipos de mieloma múltiple en recaída o refractario. Hoy en día, los científicos emplean la técnica de transfección para la producción de estas terapias. Por lo tanto, un aumento en la popularidad de las actividades de terapia celular y génica impulsa la cantidad de procedimientos de transfección realizados, lo que, a su vez, impulsa el crecimiento del mercado de equipos y reactivos de transfección en Medio Oriente y África.
Reactivos y equipos de transfección de Oriente Medio y África Descripción general del mercado
La región de Oriente Medio y África se clasifica en Arabia Saudita, Sudáfrica, Emiratos Árabes Unidos y el resto de Oriente Medio y África. Arabia Saudita tendrá la mayor participación de mercado en el año 2022.
El crecimiento de la industria farmacéutica en Medio Oriente y África está impulsado en gran medida por las inversiones realizadas por compañías farmacéuticas multinacionales en países como Arabia Saudita, Sudáfrica, Estados Unidos. Emiratos Árabes y más. En enero de 2023, el Ministerio de Inversiones de Arabia Saudita firmó dos memorandos de entendimiento para mejorar la cooperación conjunta con las industrias de biotecnología y medicina del reino. El ministerio firmó un acuerdo con la empresa alemana Boehringer Ingelheim para la mejora de la industria farmacéutica. El segundo MoU se firmó con Novo Nordisk Arabia Saudita y la Universidad de Ciencia y Tecnología Rey Abdullah con el objetivo de contribuir a brindar soluciones para desarrollar la conciencia comunitaria sobre los conceptos de trastornos metabólicos, obesidad y diabetes. Es probable que estos esfuerzos realizados para concienciar a la gente sobre las enfermedades crónicas y raras impulsen el mercado de reactivos y equipos de transfección en Arabia Saudita en los próximos años.
Además, las asociaciones entre empresas de estos países impulsan el crecimiento del mercado. En diciembre de 2021, Secondcell Bio y Alliance Care Technologies International anunciaron una nueva asociación estratégica para establecer una instalación de investigación novedosa y de vanguardia centrada en la terapia celular y Descubrimiento rápido de fármacos para combatir enfermedades genéticas raras en los Emiratos Árabes Unidos. La tecnología Chromovert está muy por delante de CRISPR y tiene un gran potencial para agilizar el proceso de descubrimiento de fármacos al permitir la generación de células que previamente fueron diseñadas para mejorar el descubrimiento de fármacos.
Ingresos del mercado de equipos y reactivos de transfección de Oriente Medio y África y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado de equipos y reactivos de transfección de Oriente Medio y África
Oriente Medio & El mercado de equipos y reactivos de transfección de África está segmentado según el producto, el método, la aplicación, el usuario final y el país.
Según el producto, el mercado de equipos y reactivos de transfección de Oriente Medio y África se divide en reactivos e instrumentos. El segmento de reactivos tuvo una participación mayor en 2022.
En términos de método, el mercado de equipos y reactivos de transfección de Oriente Medio y África está segmentado en métodos virales, métodos no virales y métodos híbridos. El segmento de métodos no virales tuvo la mayor participación en 2022. El segmento viral se subclasifica en retrovirus, adenovirus, virus adenoasociados y virus del herpes. El segmento no viral se bifurca en método físico/mecánico y método químico. Además, el segmento de métodos físicos/mecánicos se subclasifica en electroporación, microinyección, método biolístico, método láser, magnetofección y sonoporación. Además, el segmento del método químico se subcategoriza en basado en liposomas/alto en lípidos y no liposomal/alto en lípidos.
Por aplicación, el mercado de equipos y reactivos de transfección de Oriente Medio y África está segmentado en investigación biomédica, producción de proteínas y administración terapéutica. El segmento de investigación biomédica tuvo la mayor participación en 2022.
Según el usuario final, el mercado de equipos y reactivos de transfección de Oriente Medio y África se divide en académicos e institutos de investigación y empresas farmacéuticas y de biotecnología. El segmento de institutos académicos e institutos de investigación tuvo una participación mayor en 2022.
Según el país, el mercado de equipos y reactivos de transfección de Oriente Medio y África se clasifica en Sudáfrica, Arabia Saudita, los Emiratos Árabes Unidos y el resto de Oriente Medio. Este de Africa. Arabia Saudita dominó el mercado de equipos y reactivos de transfección de Oriente Medio y África en 2022.
Thermo Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV , Merck KGaA, Lonza Group AG y MaxCyte Inc son algunas de las empresas líderes que operan en el mercado de equipos y reactivos de transfección de Oriente Medio y África.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.1 Middle East & Africa Transfection Reagents and Equipment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Popularity of Cell and Gene Therapy
4.2.2 Growing Economic Burden of Cancer
4.3 Market Restraints
4.3.1 High Cost of Instruments and Consumables
4.4 Market Opportunities
4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
4.5 Future Trends
4.5.1 Strategic Initiatives by Companies
4.6 Impact of Drivers and Restraints:
5. Transfection Reagents and Equipment Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
5.2 Middle East & Africa Transfection Reagents and Equipment Market Forecast Analysis
6. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Product
6.1 Reagents
6.1.1 Overview
6.1.2 Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Equipment
6.2.1 Overview
6.2.2 Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Modality
7.1 Viral
7.1.1 Overview
7.1.2 Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.1 Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.2 Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.3 Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.1.2.4 Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Non-Viral
7.2.1 Overview
7.2.2 Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1 Physical/Mechanical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.1 Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.2 Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.3 Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.4 Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.5 Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.1.6 Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2 Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.1 Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.2.2.2.2 Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Hybrid
7.3.1 Overview
7.3.2 Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by Application
8.1 Biomedical Research
8.1.1 Overview
8.1.2 Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Protein Production
8.2.1 Overview
8.2.2 Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Therapeutic Delivery
8.3.1 Overview
8.3.2 Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Transfection Reagents and Equipment Market Analysis - by End Users
9.1 Academic and Research Institutes
9.1.1 Overview
9.1.2 Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Pharmaceutical and Biotechnological Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East and Africa Transfection Reagents and Equipment Market -Country Analysis
10.1 Middle East and Africa
10.1.1 Middle East and Africa Transfection Reagents and Equipment Market Overview
10.1.2 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.1 Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
10.1.2.2 Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.2.2.2.1 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.2.2.2.2 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.2.3 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.2.4 Saudi Arabia: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.3 South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.3.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.3.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.3.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.3.2.2.1 South Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.3.2.2.2 South Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.3.3 South Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.3.4 South Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.4 United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.4.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.4.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.4.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.4.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.4.2.2.1 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.4.2.2.2 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.4.3 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.4.4 United Arab Emirates: Transfection Reagents and Equipment Market Breakdown, by End Users
10.1.2.5 Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
10.1.2.5.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Product
10.1.2.5.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Modality
10.1.2.5.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Viral
10.1.2.5.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
10.1.2.5.2.2.1 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
10.1.2.5.2.2.2 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
10.1.2.5.3 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Application
10.1.2.5.4 Rest of Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by End Users
10.2 Inorganic Growth Strategies
10.2.1 Overview
10.3 Organic Growth Strategies
10.3.1 Overview
11. Company Profiles
11.1 Thermo Fisher Scientific Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Promega Corp
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 F. Hoffmann-La Roche Ltd
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bio-Rad Laboratories Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Mirus Bio LLC
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 QIAGEN NV
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Merck KGaA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Lonza Group AG
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 MaxCyte Inc
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About Us
List of Tables
Table 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation
Table 2. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
Table 5. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
Table 6. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
Table 7. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
Table 8. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
Table 9. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 10. Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
Table 11. Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 12. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 13. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 14. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 15. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 16. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 17. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 18. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 19. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 20. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 21. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 22. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 23. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 24. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 25. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 26. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 27. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 28. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 29. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 30. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 31. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 32. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 33. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 34. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 35. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 36. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
Table 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
Table 38. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
Table 39. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
Table 40. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
Table 41. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
Table 42. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
Table 43. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
Table 44. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
Table 45. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market
List of Figures
Figure 1. Middle East & Africa Transfection Reagents and Equipment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Middle East & Africa Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
Figure 4. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
Figure 5. Reagents: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Equipment: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
Figure 8. Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Retrovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Adenovirus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Adeno-Associated Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Herpes Virus: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Non-Viral: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Physical/Mechanical: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Electroporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Microinjection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Biolistic Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Laser Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Magnetofection: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Sonoporation: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Chemical Method: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Non-Liposomal Based/High Lipid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Hybrid: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
Figure 26. Biomedical Research: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Protein Production: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Therapeutic Delivery: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
Figure 30. Academic and Research Institutes: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 31. Pharmaceutical and Biotechnological Companies: Middle East & Africa Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Middle East and Africa: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
Figure 33. Middle East and Africa: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 34. Saudi Arabia: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 35. South Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 36. United Arab Emirates: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
Figure 37. Rest of Middle East and Africa: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa transfection reagents and equipment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in Middle East & Africa transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.